Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

West Pharmaceutical Services (NY: WST )

300.43 +1.12 (+0.37%)
Streaming Delayed Price Updated: 10:20 AM EDT, Jul 31, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 73,964
Open 299.40
Bid (Size) 299.81 (2)
Ask (Size) 301.11 (4)
Prev. Close 299.31
Today's Range 297.43 - 302.31
52wk Range 265.00 - 415.73
Shares Outstanding 73,500,000
Dividend Yield 0.25%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Balancing Dividends and Fundamentals: The Case of NYSE:WST.
Why the dividend investor may take a look at WEST PHARMACEUTICAL SERVICES (NYSE:WST). 
Via Chartmill
Ford, Stellantis And Dell Are Among Top 12 Large Cap Losers Last Week (July 21-July 27): Are The Others In Your Portfolio?
Top 10 worst performers last week: EW (-28.05%), F (-19.12%), STM (-17.60%), TER (-16.25%), MBLY (-14.61%), STLA (-13.07%), VRT (-12.04%), SMCI (-11.68%), WST (-11.37%), DELL (-11.26%), UPS (-10.96%),... 
Via Benzinga

Performance

YTD
-13.84%
-13.84%
1 Month
-7.43%
-7.43%
3 Month
-15.96%
-15.96%
6 Month
-20.12%
-20.12%
1 Year
-18.37%
-18.37%

More News

Read More
WST Stock Earnings: West Pharmaceutical Servs Misses EPS, Misses Revenue for Q2 2024
Via InvestorPlace
Why NYSE:WST is a Top Pick for Dividend Investors.
Via Chartmill
How Is The Market Feeling About West Pharmaceutical Servs?
Via Benzinga
Uncovering Dividend Opportunities with NYSE:WST.
Via Chartmill
Peering Into West Pharmaceutical Servs's Recent Short Interest
Via Benzinga
How Is The Market Feeling About West Pharmaceutical Servs?
Via Benzinga
Why the dividend investor may take a look at NYSE:WST.
Via Chartmill
Why Edwards Lifesciences Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
WST Stock Earnings: West Pharmaceutical Servs Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
(WST) - Analyzing West Pharmaceutical Servs's Short Interest
Via Benzinga
Exploring NYSE:WST's dividend characteristics.
Via Chartmill
Analyzing NYSE:WST's Dividend Potential.
Via Chartmill
(WST) - Analyzing West Pharmaceutical Servs's Short Interest
Via Benzinga
3 Pharma Stocks to Sell in March Before They Crash & Burn
Via InvestorPlace
S&P Reclaims 5,000 As Disappointing Retail Sales Put Fed Cuts Back On Track, Small Caps Shine: What's Driving Markets Thursday?
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
West Pharmaceutical's 2024 Outlook Cautious, Analysts Remain Optimistic
Via Benzinga
West Pharmaceutical Sets 2024 EPS Guidance at $7.50-$7.75
Via Talk Markets
Earnings Scheduled For February 15, 2024
Via Benzinga
Why WEST PHARMACEUTICAL SERVICES (NYSE:WST) qualifies as a quality stock.
Via Chartmill
Why Herbalife Shares Are Trading Lower By Around 36%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Keybanc Maintains Overweight Rating for West Pharmaceutical Servs: Here's What You Need To Know
Via Benzinga
TransDigm, West Pharmaceutical, Thermo Fisher Scientific And A Tech Company On CNBC's 'Final Trades'
Via Benzinga
Here's How Much You Would Have Made Owning West Pharmaceutical Servs Stock In The Last 10 Years
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.